This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sato, K. Articles by Obara, T. Search for Related Content PubMed PubMed Citation Articles by Sato, K. Articles by Obara, T.

Increased Concentration of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Cyst Fluid of Enlarging and Recurrent Thyroid Nodules¹

Department of Medicine(K.S., Me.M., N.O., H.D.) and Department of Surgery (K.Y., T.O.), Institute of Clinical Endocrinology, Tokyo Women’s Medical College; Second Department of Pathology (T.K.), Tokyo Women’s Medical College, Shinjuku-ku, Tokyo 162; and Mitsubishi-Kagaku Biochemical Laboratories (T.Y., Ma.M.) Itabashi-ku, Tokyo 111, Japan

Address all correspondence and requests for reprints to: Kanji Sato, Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women’s Medical College, Kawada-cho 8–1, Shinjuku-ku, Tokyo 162, Japan.

Human thyrocytes produce vascular endothelial growth factor (VEGF), a potent angiogenic factor, also known as vascular permeability factor (VPF), which increases vascular permeability. Based on the assumption that VEGF/VPF is involved in fluid accumulation in thyroid cysts, we determined the VEGF/VPF concentration in cyst fluids of thyroid nodules from 79 patients. VEGF/VPF was found to be abundantly present in the cyst fluids (0.02–183 ng/mL). There was no significant difference of VEGF/VPF concentration in the cyst fluid obtained from thyroid adenoma or from adenomotous goiter with cystic degeneration. Immunoreactive VEGF/VPF in cyst fluid was eluted mainly at 45 kDa, and stimulated endothelial cell proliferation, which was partially blocked by anti-VEGF/VPF antibody. The VEGF/VPF concentration in the cyst fluid obtained from patients who required repeated aspiration or underwent surgical resection because of recurrent accumulation (84.8 ± 58.3 ng/mL, mean ± SD, n = 18) was significantly higher than that in the cysts that regressed or disappeared after a single aspiration (4.3 ± 4.4 ng/mL, n = 12, P < 0.001).

These in vitro and clinical findings suggest that VEGF/VPF is at least partly involved in the accumulation of cyst fluid in thyroid nodules, and that a high VEGF/VPF concentration predicts rapid accumulation of the cyst fluid, possibly necessitating interventional treatment.

This article has been cited by other articles:

				S. Hoffmann, L. C. Hofbauer, V. Scharrenbach, A. Wunderlich, I. Hassan, S. Lingelbach, and A. Zielke Thyrotropin (TSH)-Induced Production of Vascular Endothelial Growth Factor in Thyroid Cancer Cells in Vitro: Evaluation of TSH Signal Transduction and of Angiogenesis-Stimulating Growth Factors J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6139 - 6145. [Abstract] [Full Text] [PDF]

				A. Fasciani, G. D'Ambrogio, G. Bocci, M. Monti, A.R. Genazzani, and P.G. Artini High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata Mol. Hum. Reprod., January 1, 2000; 6(1): 50 - 54. [Abstract] [Full Text] [PDF]

				K. Suzuki, A. Mori, J. Saito, E. Moriyama, L. Ullianich, and L. D. Kohn Follicular Thyroglobulin Suppresses Iodide Uptake by Suppressing Expression of the Sodium/Iodide Symporter Gene Endocrinology, November 1, 1999; 140(11): 5422 - 5430. [Abstract] [Full Text]

				D.-s. Cheng, R. M. Rodriguez, E. A. Perkett, J. Rogers, G. Bienvenu, U. Lappalainen, and R. W. Light Vascular Endothelial Growth Factor in Pleural Fluid Chest, September 1, 1999; 116(3): 760 - 765. [Abstract] [Full Text] [PDF]